CD3D encodes the CD3δ subunit, an essential component of the T-cell receptor (TCR) complex that plays critical roles in T-cell development and immune function. CD3D is required for proper thymocyte differentiation, as mutations in CD3D cause a complete block in T-cell development at the transition between double-negative and double-positive thymocytes, resulting in severe combined immunodeficiency (SCID) 1. The protein contains immunoreceptor tyrosine-based activation motifs (ITAMs) that become phosphorylated upon TCR engagement, initiating downstream signaling cascades essential for T-cell activation. Recent therapeutic advances demonstrate that adenine base editing can restore CD3δ function in patient hematopoietic stem cells, with edited cells successfully differentiating into mature T cells with diverse TCR repertoires 2. In cancer contexts, high CD3D expression correlates with favorable prognosis and enhanced immune cell infiltration, serving as a biomarker for immunotherapy response 3. Conversely, reduced CD3D expression is associated with poor outcomes in septic shock 4. CD3D expression is regulated by various mechanisms, including miRNA networks and cis-regulatory interactions with other loci such as JAML 5. These findings highlight CD3D's fundamental importance in adaptive immunity and its potential as both a therapeutic target and prognostic marker.